Information Journal Paper
APA:
Copy. (2019). Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 27(-), 101-111. SID. https://sid.ir/paper/768268/en
Vancouver:
Copy. Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US. MULTIPLE SCLEROSIS AND RELATED DISORDERS[Internet]. 2019;27(-):101-111. Available from: https://sid.ir/paper/768268/en
IEEE:
Copy, “Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US,” MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol. 27, no. -, pp. 101–111, 2019, [Online]. Available: https://sid.ir/paper/768268/en